Theme:
Immuno Oncology 2020
Cancer:
When the body's control mechanism disruptions working properly and the cells remain no longer normal, they start growing abnormally and uncontrollably, hence causing Cancer. Old cells do not die and as an alternative grow out of control, forming new, abnormal cells. These extra cells may arrangement a mass of tissue, called a tumor. A tumor can be benign and malignant as well. Benign tumors lack the capacity to metastasize whereas malignant are life-threatening and metastasize which leads to cancer.
There are different types of cancers. Despite of their arrivals to grow, divide & re-divide (instead of dying) and founding new abnormal cells, some types of cancer cells often travel to other parts of the body through blood circulation or lymph vessels (metastasis), where they initiate to grow. Different types of cancer cells can behave differently.
The risk of emerging many types of cancers can be reduced by changes in lifestyle by leaving smoking and eating low fat diet, etc., If cancer is identified in early stage it is easy to treat and may have healthier chances for living many years.
Importance and Scope
2020 Global Cancer Summit will be the best stage for all the scientist, radiologist. The Global Cancer Summit 2020 is the premier event that brings together International experts, Training Institutes, Manufacturing Medical Devices Companies, Business Entrepreneurs, Medical Colleges, Researchers, Academicians, Physicians, Post Docs, Students, Pharmacy Industries, Academic scientists, Industry professionals, Diagnostic laboratory professionals and decision makers across the globe to exchange their knowledge, experience and research innovations to build Cancer Research scientists to reduce the global burden of cancer.
Global Cancer Summit 2020 is an extraordinary event designed for International medical health professionals and oncologists to facilitate the dissemination and application of new research findings related to Cancer. The conference invites participants from all leading universities, clinical research institutions and diagnostic companies to share their research experiences on all aspects of this rapidly expanding field and thereby, providing a showcase of the latest techniques.
Why you should attend Immuno Oncology 2020??
International conferences are great openings not only for researchers and scientists, but also for experts, policy makers, stakeholders and students. There is an plenty of academic conferences today as compared to the past. This brings us to a simple question, “Why should one join an academic conference?” Below are explanations why people say they attend our conferences.
At a conference, advanced ideas are thrown about, and new information is exchanged among experts. Its resolution could be one of the following: An academic conference is a gathering of scientists or academicians, where research findings are presented, or a workshop is conducted.
Attending a seminar has numerous benefits, including improving communication skills, gaining expert knowledge, networking with others and renewing motivation and confidence.
Learning: Joining conferences, especially the international ones, gives you the chance to listen to different points of view and learn new ideas and trends in your field. They also provide you with new procedures, new types of equipment, data that is yet to be published, and investigators that you may not have heard of. Conferences are precious chances to sharpen your saw by learning new skills in a different environment.
Discussion: Attending conferences agrees you to learn new information and tactics from hearing others’ presentations, you also can contrary with other researchers from different universities and even countries you may have only heard or read about.
Presentation: Presenting your exploration in a conference helps you in different ways. It grants your work to the scientific circles and helps to improve your work by getting feedback from the experts and influencers in your field. Presenting a paper is one of the key objectives of an academic conference participant. The presenter will have the casual to present a paper in front of colleagues of the same or similar fields of study and will be able to receive positive feedback and constructive criticism about their research. The argument of ideas on fields of interests seeds the links for future collaborations across the world.
Visiting a new place: Attending conferences permits you to discover a new place or city where the conference is being held and learn about its people and culture. Numerous conferences support their attendees with a list of great places they can visit in the conference’ city or country. You can also range your participation in the conference to a well-deserved holiday in that country and have memorable days.
Interacting for future collaborations: International Conferences are great opportunities to connect with attendees from different perspectives and views, learn from them, make new relationships, and strengthen existing ones. Conferences cover the way for scientific cooperation by meeting and connecting with researchers from different countries. They also help in collaborating collective research projects such as edited books, special issues in peer-reviewed journals or funding applications. In count, Conferences allow Experts, Stakeholders and Policymakers to communicate with researchers with innovative approaches and benefit from these relations in their businesses. Attending a hypothetical conference is an opportunity to build networks with other academics and experts in the same or similar field of studies all around the world and to share thoughts on recent advances and technological breakthroughs.
Publication: Added common reason for attending a conference is no doubt publication. Conference records are always a good way to have your research published and indexed. You’ll also have the chance to publish your research in one of the journals.
Conclusion:
In today’s fast-moving world, attending a conference has become a “must” to survive in an academic discipline. Many researchers have become aware of this fact as the number of conferences and participants increase dramatically. We look forward to collaborating with you at Immuno Oncology 2020.
Enlightening public with current advances in Cancer diagnosis and therapy from around the world focused on cancer about recent advances in Cancer diagnosis and therapy, this is your single best opportunity to reach the largest assemblage of participants. World-renowned speakers, the maximum recent techniques, and the newest updates in cancer research fields are hallmarks of this conference. Conferences, Nationwide symposiums and Workshops provide a dedicated forum for the advancement, execution and exchange of information about Cancer.
Who Should Attend World Cancer 2020??
Oncologists, Radiologists, Chemotherapists, Physicians, Academicians, Manufacturing professionals, Diagnostic laboratory professionals, Academic scientists, Postgraduate students, Postdoctoral fellows, and Trainees can attend.
All individuals engaged in cancer care operations should attend the " Immuno Oncology 2020", including:
- Hospital Presidents/CEOs/COOs/VPs/Trustees
- Hospital c-suite executives (operations, development, Finance)
- Medical Directors
- Oncology specialists (Medical, Radiation and Surgical)
- Oncology program and practice administrators, managers and service line executives.
- Health care consultants, vendors and suppliers
- Pharmaceutical and biotechnology manufacturers
- Cancer program marketing and public relations professionals.
\r\n Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A medical professional who practices oncology is an oncologist. An oncologist manages a patient’s care throughout the course of the disease. This starts with the diagnosis. Different types of doctors often work together to create a patient’s overall treatment plan that combines different types of treatments. For instance, a patient may need treatment with a combination of surgery, chemotherapy, and radiation therapy. This is called a Multidisciplinary team.
\r\n
\r\n
\r\n
\r\n Clinical oncology enfolds the non-surgical aspect of oncology. 85% of all clinical oncologists treat patients with a balance of chemotherapy and radiotherapy. Clinical oncologists are involved in the treatment of all types of cancer. They work intently in large multidisciplinary teams that focus on the treatment of cancer affecting parts of the body or systems. They treat patients and manage their cancer throughout the disease. This specialty gives the opportunity of developing clinical and scientific skills with great potential for academic and clinical research. Technologies in the field of clinical oncology are improving promptly. For example, some tumours can be treated with highly sophisticated precision external beam radiation therapy such as proton beam therapy. Some patients can be cured, but for others the emphasis is on effective palliative care and improving quality of life.
\r\n
\r\n
\r\n
\r\n The study of epigenetic modifications to the genome of cancer cells that do not include a change in the nucleotide sequence is known as Cancer Epigenetics. Epigenetic alterations are as important as genetic mutations in a cell's transformation to cancer and their manipulation embraces great potential for cancer prevention, detection, and therapy. A variety of compounds are considered as epigenetic carcinogens such as arsenite, diethylstilbestrol, hexachlorobenzene and nickel compounds. They result in an increased incidence of tumors, but they do not show mutagen activity.
\r\n
\r\n
\r\n
\r\n It is one of the three basic specialties, the other two being surgical and therapeutic oncology, related with the treatment of development. Radiation can be given as a therapeutic system, either alone or in mix with surgery or possibly chemotherapy. The mission of Advances in Radiation Oncology is to give unique clinical research went for improving the lives of people living with tumour and distinctive ailments treated with radiation treatment.
\r\n
-
\r\n
- \r\n Radiation Therapy \r\n
- \r\n Predictive Oncology \r\n
- \r\n Cancer Imaging \r\n
- \r\n Stem Cell Therapy \r\n
- \r\n Oncology Nursing \r\n
\r\n
\r\n
\r\n
\r\n A nursing professional who specializes in caring for people with Cancer is an Oncology Nurse. They monitor physical conditions, prescribe medication, and administer chemotherapy and other treatments. Oncology is one of the most challenging and gratifying fields in nursing.
\r\n
\r\n The scope of oncology nursing extents from prevention and early stage diagnosis to treatment (such as surgical oncology, radiation oncology, medical oncology) through symptom management and palliative care. Oncology nurses have a cancer-specific knowledge base and clinical specialize in cancer. Oncology nurses must inspect numerous details about each patient and they must tend to several patients each day. One mistake could affect a patient’s health, so their attention to detail is critical.
\r\n
\r\n Oncology nursing care can defined as meeting the various needs of oncology patients during the time of their disease including appropriate screenings and other preventative practices, symptom management, care to retain as much normal functioning as possible, and supportive measures upon end of life.
\r\n
\r\n
\r\n
\r\n It is known a leukaemia, blood cells are made inside your bone marrow, and that’s where leukemia starts. It causes your body to make white blood cells that grow out of control and live longer than they’re supposed to. And unlike normal white blood cells, they don’t help your body fight infection.
\r\n
\r\n There are many different forms of leukemia. Some get worse quickly (acute). You’ll probably feel very sick very suddenly, like you’ve come down with the flu. Other forms can take years to cause symptoms (chronic). Your first clue may be abnormal results on a routine blood test.
\r\n
\r\n Most signs of leukemia happen because the cancer cells keep your healthy blood cells from growing and working normally.
\r\n
\r\n
\r\n
\r\n Cancer Treatments are medical therapies that asserted to treat cancer by different methods like surgery, chemotherapy, radiation oncology, and immunotherapy. Oncolytic biotherapy is a rising treatment method of cancer which uses infections to destroy cancers. The recent development in genetic engineering techniques has been made using viruses to attack and destroy cancer cells. Chemotherapy is a method of cancer treatment which uses chemical substances or chemotherapeutics drug to kill the cancerous cells.
\r\n
\r\n It is one of the major methods of medical oncology.
\r\n
-
\r\n
- \r\n Surgery \r\n
- \r\n Chemotherapy \r\n
- \r\n Radiotherapy \r\n
\r\n
\r\n
\r\n
\r\n Hematologic Oncology is the branch of medicine study about the diagnosis ,prevention, treatment, and avoidance of disease identified with blood. Hematology incorporates the study of etiologist includes treating disease that influence the production of blood and its parts, for example, platelets, hemoglobin, blood proteins, bone marrow, platelets, veins, spleen, and the component of coagulation.
\r\n
\r\n The research facility work that goes into the study of blood is much of the time performed by a medical technologist or therapeutic lab researcher. Hematologists also conduct study in oncology and work with oncologists, individuals who may specialize just in that field rather than both-the therapeutic treatment of tumor.
\r\n
\r\n There are different disorders that people are influenced by hematology. A couple of these different type of blood conditions that are looked at incorporate anaemia, hemophilia, general blood clots, bleeding disorders, and so forth. With respect to related blood diseases, for example, leukemia, myeloma, and lymphoma, these are more serious cases that should be analysed.
\r\n
\r\n
\r\n
\r\n Cancer is one among the primary causes of death all over the world. Organ Specific Cancers are cancers named based on the location of cancer in the parts of the body. There are different types of cancers, some of them are Head and Neck Cancer, Brain cancer, Lung cancer, Oral cancer, Liver cancer, Breast cancer, Prostate cancer, Gastric cancer, Pancreatic cancer, Kidney (Renal Cell) cancer, Leukemia and many more.
\r\n
\r\n Lung, prostate, colon, rectum, stomach and liver are the most common organs affected by cancer in men. The most common organs affected by cancer in women are breast, colon, rectum, lung, cervix and stomach.
\r\n
\r\n
\r\n
\r\n This transformation is determined by both inherited genetic factors and somatic genetic alterations and mutations, and it results in uncontrolled cell growth and leads to death. The genetic mutations that lead to cancer occur only in certain genes. Cancer-causing genes have been classified as proto-oncogenes (e.g., the genes for MYC, ERBB2 and EGFR) and tumor suppressor genes such as the genes that encode TP53, CDKN2A, and RB.
\r\n
\r\n The completion of the Human Genome Project simplified the field of oncogenomic and improved the abilities of researchers to find oncogenes. Sequencing technologies and global methylation profiling methods are practiced to the study of oncogenomics.
\r\n
\r\n
\r\n
\r\n Biomarkers are molecules that indicate normal or abnormal process occur in your body. Biomarkers may be produced by the cancer tissue itself or by other cells in the body in response to cancer. It is especially used for the identification of breast cancer.
\r\n
\r\n They can be found in the blood, stool, urine, tumour tissue and bodily fluids. Cancer biomarkers can include Proteins, Gene mutations (changes), Gene rearrangements, Extra copies of genes, Missing genes and Other Molecules Biomarkers helps in cancer research to diagnose the early stage cancers, find out the aggressiveness and develop cancer drugs.
\r\n
\r\n
\r\n
\r\n
\r\n
\r\n The term phenotype can be used in clinical medicine for speaking about the presentation of a disease. The study and practice of medicine based on direct observation of patients. Clinical medicine is a field of medicine that deals primarily with the practice and study of medicine based on the direct examination of the patient. In clinical medicine, medical practitioners assess patients in order to diagnose, treat, and prevent disease.
\r\n
\r\n
\r\n
\r\n Alternative cancer treatments cannot help in curing your cancer, but help to relieve symptoms and improve quality of life during cancer treatment.
\r\n
\r\n Common signs and symptoms such as anxiety, fatigue, nausea and vomiting, pain, difficulty sleeping, and stress may be lessened by alternative treatments. Integrating the best of evidence-based complementary and alternative cancer treatments with the treatments you receive from your doctor may help relieve many of the symptoms associated with cancer and its treatment.
\r\n
\r\n
\r\n
\r\n All the more unequivocally, in light of the fact that growth traverses numerous organic, spatial and transient scales, correspondence and input instruments over the scales make a profoundly complex dynamic framework.
\r\n
\r\n The connections between scales are not basic or fundamentally immediate, and now and again wind up noticeably combinatorial, so frameworks approaches are basic to assess these connections quantitatively and subjectively.
\r\n
\r\n Malignancy frameworks science hence receives an all-encompassing perspective of growth went for incorporating its numerous organic scales, including hereditary qualities, flagging systems, epigenetics, cell conduct, histology, (pre)clinical indications and the study of disease transmission.
\r\n
\r\n
\r\n
To share your views and research, please click here to register for the Conference.
To Collaborate Scientific Professionals around the World
Conference Date | September 24-25, 2020 | ||
Sponsors & Exhibitors |
|
||
Speaker Opportunity Closed | |||
Poster Opportunity Closed | Click Here to View |
Useful Links
Special Issues
All accepted abstracts will be published in respective Our International Journals.
- Journal of Oncology Research and Treatment
- Journal of Cancer Science & Therapy
- Journal of Clinical & Experimental Oncology
Abstracts will be provided with Digital Object Identifier by